Life science organizations play a vital role in fighting the coronavirus pandemic. We know that conquering a disease that is putting considerable strain on current healthcare services and sending economic shockwaves around the globe is of paramount importance. Atos is uniquely positioned to enable life sciences and other research organizations to:
- Reduce R&D costs through digital applications in the clinical trial phase, ensuring full regulatory compliance through the TMF process
- Reduce costs through digitally enabled operational efficiencies in the drug manufacturing phase
- Accelerate speed to market for drugs and vaccines, reducing costs to market and maintaining competitive advantage
- Innovate your digital workplace with a secure and cost-effective methodology, delivering flexibility and greater productivity.
Expert resource & staff with critical skills to support rapid digital change and service delivery.
Maintaining patient trial, contact and support services via remote, geo-redundant contact centers.
Ensuring your staff have the equipment they need to work effectively from any location.
Selection, deployment and optimization of remote working software and virtual desktop infrastructure to support home and anywhere working.
Data & Security Continuity
Data & security regulatory compliance
Providing advisory services around data practices to ensure certainty of compliance during homeworking.
Increase in cyber security threats and attacks
Protecting vital services and confidential information from unwarranted attacks.
Meet our customers:
Atos’ Canopy Open Hybrid Cloud platform, launched in 1H19, will support Philips on its journey toward cloud-native application delivery services over the next few years.
Johnson & Johnson has renewed its contract with Atos to deploy Digital Workplace technologies across its organization to improve productivity while also controlling costs.
Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection
Atos announce that the Biocomputing Unit at the Spanish National Center…
Atos establishes Life Sciences Centre of Excellence to support researchers worldwide
Atos in agreement with the Wellcome Genome Campus, in Cambridgeshire, UK, today announces its global HPC, AI & Quantum Life Sciences Centre…
University of Reims Champagne-Ardenne (URCA) uses Atos supercomputer to accelerate research against COVID-19
Atos announces that the University of Reims Champagne-Ardenne (URCA)’s supercomputer, named ROMEO, is now…
Atos and Siemens introduce Digital Twin solution within the global pharmaceutical industry
Atos, a global leader in digital transformation and Siemens, a global engineering leader, are working together with the pharmaceutical industry…
The role of digital twins in producing a COVID-19 vaccine
Accelerating drug production Immunization and vaccines prevent 4-5 million deaths every year according to the WHO. Once a vaccine has been…
Atos mobilizes technological expertise to fight Covid-19
Atos brings its technology leadership, skills and innovation resources to the global fight against Covid-19
How artificial intelligence, robotics and Big Data can support pandemic situations
Daniel Calvo Head of Artificial Intelligence and Robotics. Atos Research and InnovationOrlando Ávila Artificial Intelligence and Robotics Associated Head. Atos Research…
Collective intelligence — a key differentiator for organizations in the post-COVID era
The resilience of every organization on the planet is being tested in every possible way by the sheer…